Las glucogenosis son enfermedades hereditarias del metabolismo del glucógeno. Se reconocen más de 12 tipos y afectan principalmente al hígado y al músculo, by Glycogen storage disease 1b: Speculation on the role of autoimmunity. Tratamiento continuo con factores estimulantes de colonias (G-CSF) de la neutropenia asociada a la glucogenosis tipo IbTreatment with granulocyte colony . A glycogen storage disease (GSD) is the result of an enzyme defect. These enzymes normally catalyze reactions that ultimately convert.

Author: Gaktilar Akill
Country: Suriname
Language: English (Spanish)
Genre: Marketing
Published (Last): 22 May 2017
Pages: 192
PDF File Size: 12.32 Mb
ePub File Size: 16.49 Mb
ISBN: 503-5-82396-954-2
Downloads: 65690
Price: Free* [*Free Regsitration Required]
Uploader: Gokus

Variants listed in the table have been provided by the authors. Other family members of a proband.


A further effect of chronic lactic acidosis in GSD I is hyperuricemia, as lactic acid and uric acid compete for the same renal tubular transport mechanism. Differential diagnoses include the other glycogenoses, in particular glycogenosis due to glycogen debranching enzyme deficiency GDE deficiency or GSD type III see this term but in this case, glycemia and lactacidemia are high after a meal and low in a fasting period. Long-term complications of untreated GSDI include growth retardation resulting in short stature, osteoporosis, delayed puberty, gout, renal disease, pulmonary hypertension, hepatic adenomas with potential for malignant transformation, polycystic ovaries, pancreatitis, and changes in brain function.

Heterozygote carriers are asymptomatic.

Hyperoxaluria Primary hyperoxaluria Pentosuria Aldolase A deficiency. For about 3 hours after a carbohydrate-containing meal, high insulin levels direct liver cells to take glucose from the blood, to convert it to glucosephosphate G6P with the enzyme glucokinase, and to add the G6P molecules to the ends of chains of glycogen glycogen synthesis.

More than pathogenic variants that are scattered throughout the gene have been reported see Table A.

Once the diagnosis is suspected, the glucogenoxis of clinical and laboratory features usually makes a strong circumstantial case. Small frequent meals and snacks high in complex carbohydrates with additional feedings between meals and before bedtime are recommended monitoring of blood glucose concentration may help adjust feeding schedules to meet glcuogenosis needs. Clinical Characteristics Clinical Description The clinical manifestations of glycogen storage disease type I GSDI are growth retardation leading to short stature and accumulation of glycogen and fat in liver and kidneys resulting in hepatomegaly and renomegaly, respectively [ Kishnani et al ].


More than pathogenic variants are known see Table A. If these are developing, intravenous fluids should be provided at a rate above maintenance. Genetic Counseling Genetic counseling is the process of providing individuals and families with information on the nature, inheritance, and implications of genetic disorders to help them make informed medical and personal decisions. In affected individuals who are 16 years and older, liver computed tomography CT or magnetic resonance imaging MRI scanning using intravenous contrast should be done every six to 12 months to monitor for hepatic adenoma formation [ Franco et al ].

Impairment of glycogenolysis also causes the characteristic enlargement of the liver hepatomegaly due to accumulation of glycogen. The genes included and the sensitivity of multigene panels vary by laboratory and over time. Triglyceride levels in GSD I can reach several times normal and serve as a clinical index of “metabolic control”.

The increased frequency of some pathogenic variants in different ethnic groups e. gluocgenosis

Glycogen Storage Disease Type I – GeneReviews® – NCBI Bookshelf

By the second or third decade of life, most affected individuals exhibit hepatic adenomas, a complication of which is intrahepatic hemorrhage. Genetic testing of glycogen storage disease type Ib in Japan: Severe cardiomyopathy revealing amylopectinosis.

Natural history of hepatocellular adenoma formation in glycogen storage disease type I. Glucosephosphatase mutation GR confers an atypical glucogenossi storage disease type Ib phenotype.

This method requires a nasogastric or gastrostomy tube and pump.

Glycogen storage disease type I – Wikipedia

Other liver functions are usually spared, and liver enzymes and bilirubin are usually normal. Hence, the classification of GSDI into four subtypes no longer exists. Mutations in the glucosephosphatase gene of 53 Italian patients with glycogen storage disease type Ia. From Wikipedia, the free encyclopedia. Type III glycogen storage disease is a hereditary disorder with autosomal recessive transmission.

Glycogen storage disease type I

Clinical outcome of hepatocyte transplantation in four pediatric patients with inherited metabolic diseases. Evaluation of Relatives at Risk Evaluation of sibs of a proband as early as possible allows for prompt diagnosis and treatment with much-improved outcome.


A critical blood specimen obtained at the time of hypoglycemia typically reveals a mild metabolic acidosis, high free fatty acids and beta-hydroxybutyrate, very low insulin levels, and high levels of glucagon, cortisol, and growth hormone. Diet should be low in fructose and sucrose; galactose and lactose intake should be limited to one serving per day; combined oral contraception should be avoided in women, particularly those with adenomas.

Type 1 glycogen storage disease and recurrent calcium nephrolithiasis. GeneReviews is a registered trademark of the University of Washington, Seattle. The brain’s habituation to mild hypoglycemia is at least partly explained by use of alternative fuels, primarily lactate. The liver edge glucoggenosis often at or below the level of the umbilicus. There is some evidence that metabolic control of the disease is a factor.

With disease progression, interstitial fibrosis becomes evident. Hepatic adenomas can be treated with surgery or other interventions including percutaneous ethanol injections and radiofrequency ablation. Systemic blood pressure measurements should be obtained at all clinic visits beginning in infancy. Glycogen storage disease type II: February Learn how and when to remove this template message.

Manifestations include epistaxis, easy bruising, menorrhagia, and bleeding during surgical procedures. Health care resources for this disease Expert centres Diagnostic tests Patient organisations 81 Orphan drug s Summary Epidemiology Prevalence is unknown. In fact the effect is amplified because the resulting high glycogenosis of glucosephosphate inhibit earlier key steps in both glycogenolysis and glucogenosie. Limit galactose and lactose intake to one serving per day.

Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study. GlnTer can be performed first in individuals of Old Order Amish ancestry. Follow GSDI guidelines published recently through a group of experts in the field [ Kishnani et al ]. Despite hyperlipidemia, atherosclerotic complications are uncommon.